272 related articles for article (PubMed ID: 14982975)
1. Guidelines for acute decompensated heart failure treatment.
DiDomenico RJ; Park HY; Southworth MR; Eyrich HM; Lewis RK; Finley JM; Schumock GT
Ann Pharmacother; 2004 Apr; 38(4):649-60. PubMed ID: 14982975
[TBL] [Abstract][Full Text] [Related]
2. Hospital policies for treatment of acute decompensated heart failure.
Vats V; DiDomenico RJ; Wojtynek JE; Theobald JC; Schumock GT
Ann Pharmacother; 2007 Apr; 41(4):562-7. PubMed ID: 17374618
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for acute decompensated heart failure.
Southworth MR
Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S7-15. PubMed ID: 12966901
[TBL] [Abstract][Full Text] [Related]
4. Congestive Heart Failure.
Scott MC; Winters ME
Emerg Med Clin North Am; 2015 Aug; 33(3):553-62. PubMed ID: 26226866
[TBL] [Abstract][Full Text] [Related]
5. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
6. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
7. What is evidence-based, what is new in medical therapy of acute heart failure?
Grimm W
Herz; 2006 Nov; 31(8):771-9. PubMed ID: 17149679
[TBL] [Abstract][Full Text] [Related]
8. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
9. Optimizing outcomes in the patient with acute decompensated heart failure.
Mehra MR
Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617
[TBL] [Abstract][Full Text] [Related]
10. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
[TBL] [Abstract][Full Text] [Related]
11. Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
Givertz MM; Teerlink JR; Albert NM; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Fang JC; Hernandez AF; Katz SD; Krishnamani R; Stough WG; Walsh MN; Butler J; Carson PE; Dimarco JP; Hershberger RE; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Starling RC
J Card Fail; 2013 Jun; 19(6):371-89. PubMed ID: 23743486
[TBL] [Abstract][Full Text] [Related]
12. Advances in chemical pharmacotherapy for managing acute decompensated heart failure.
Yandrapalli S; Tariq S; Aronow WS
Expert Opin Pharmacother; 2017 Apr; 18(5):471-485. PubMed ID: 28276970
[TBL] [Abstract][Full Text] [Related]
13. The benefits of early vasoactive therapy in the treatment of acute decompensated heart failure.
Albert NM
J Am Acad Nurse Pract; 2005 Oct; 17(10):403-10. PubMed ID: 16181262
[TBL] [Abstract][Full Text] [Related]
14. Acute decompensated heart failure: formulating an evidence-based approach to diagnosis and treatment (part II).
Buccelletti F; Hermann L
Mt Sinai J Med; 2006 Mar; 73(2):516-27. PubMed ID: 16568194
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Saltzberg MT
Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
[TBL] [Abstract][Full Text] [Related]
16. Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Emerman CL
Rev Cardiovasc Med; 2003; 4 Suppl 7():S13-20. PubMed ID: 14668696
[TBL] [Abstract][Full Text] [Related]
17. Hospitalized patients with acute decompensated heart failure: recognition, risk stratification, and treatment review.
Amin A
J Hosp Med; 2008 Nov; 3(6 Suppl):S16-24. PubMed ID: 19084891
[TBL] [Abstract][Full Text] [Related]
18. Acute decompensated heart failure: evolving literature and implications for future practice.
Cicci JD; Reed BN; McNeely EB; Oni-Orisan A; Patterson JH; Rodgers JE
Pharmacotherapy; 2014; 34(4):373-88. PubMed ID: 24214219
[TBL] [Abstract][Full Text] [Related]
19. Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
Wang XC; Zhu DM; Shan YX
Am J Cardiovasc Drugs; 2015 Dec; 15(6):429-37. PubMed ID: 26123415
[TBL] [Abstract][Full Text] [Related]
20. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
